Dr. Renan Amphilophio Fernandes develops projects in the area of clinical research as a postdoctoral researcher at the Translational Neuroscience Laboratory (UNIRIO) (FAPERJ Fellow), where he develops lines of research in genetic analysis (Next Generation Sequencing) and plasma biomarkers (SIMOA) associated with demyelinating, neuroinflammatory, and viral diseases associated with neurological manifestations, such as arboviruses and COVID-19. Graduated in Biological Sciences at the Veiga de Almeida-RJ University, with improvement at the National Cancer Institute (INCA); master's in the Graduate Program in Clinical and Experimental Pathology (FISCLINEX) at the State University of Rio de Janeiro (UERJ); and PhD in the program of Pharmacology and Medicinal Chemistry (PPGFQM) of the Federal University of Rio de Janeiro (UFRJ), with experience in the following subjects: cell models, cell biology, molecular biology, biochemistry, pharmacology, cancer, tumor metabolism, and histone deacetylase inhibitors.
Dr. Renan Amphilophio Fernandes develops projects in the area of clinical research as a postdoctoral researcher at the Translational Neuroscience Laboratory (UNIRIO) (FAPERJ Fellow), where he develops lines of research in genetic analysis (Next Generation Sequencing) and plasma biomarkers (SIMOA) associated with demyelinating, neuroinflammatory, and viral diseases associated with neurological manifestations, such as arboviruses and COVID-19. Graduated in Biological Sciences at the Veiga de Almeida-RJ University, with improvement at the National Cancer Institute (INCA); master's in the Graduate Program in Clinical and Experimental Pathology (FISCLINEX) at the State University of Rio de Janeiro (UERJ); and PhD in the program of Pharmacology and Medicinal Chemistry (PPGFQM) of the Federal University of Rio de Janeiro (UFRJ), with experience in the following subjects: cell models, cell biology, molecular biology, biochemistry, pharmacology, cancer, tumor metabolism, and histone deacetylase inhibitors.